ArticleBiologics : targets & therapy2008

Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer.

Eduardo Lasalvia-Prisco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.